ID Genomics
Seattle-based Idgenomics Inc, founded in 2012, provides professional medical analytics and diagnostics.
Founded
2012Seattle-based Idgenomics Inc, founded in 2012, provides professional medical analytics and diagnostics.
Seattle-based ID Genomics Inc, founded in 2012, specializes in providing professional medical analytics and diagnostic services. The company's core mission is to personalize the treatment of infectious diseases through advanced diagnostics. Their product line includes Bacterial Collections, CLoNeT™, and BactNeT™, which offer comprehensive solutions for antibiotic susceptibility testing, Staphylococcus aureus SPA typing, and metagenomics analysis. ID Genomics primarily focuses on healthcare providers and researchers seeking precise diagnostic tools to improve patient outcomes.
Notable figures affiliated with ID Genomics include its founding team of experts in microbiology and genomics. The company has garnered attention from prominent investors in the biotech sector. Key achievements include the development of proprietary technologies like CLoNeT™ and BactNeT™, which have significantly impacted the field of infectious disease diagnostics. Overall, ID Genomics has made substantial contributions to personalized medicine by enhancing the accuracy and efficiency of diagnostic processes, thereby improving treatment strategies for infectious diseases.
Companies similar to ID Genomics include Aperiomics, Day Zero Diagnostics, Inform Genomics and GeneCapture.
ID Genomics was founded in 2012.
ID Genomics' headquarters is located in Seattle, WA, US.
ID Genomics' most recent funding round was for $300k (USD) in August 2021.
As of Aug 24, 2021, ID Genomics has disclosed funding of $3.4M (USD). Undisclosed round amounts are excluded.
ID Genomics has 8 employees as of Feb 5, 2024.
GeneCapture
genecapture.com
